Tech Company Financing Transactions

AtaCor Medical Funding Round

Arboretum Ventures, Catalyst Health Ventures and Hatteras Venture Partners participated in a $28 million Series C funding round for AtaCor Medical. The round closed on 4/25/2024.

Transaction Overview

Company Name
Announced On
4/25/2024
Transaction Type
Venture Equity
Amount
$28,000,000
Round
Series C
Investors
Proceeds Purpose
The company intends to use the funds to support FDA submission for its extravascular temporary pacing lead system as well as completion of a pilot study for the third generation EV-ICD lead system.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
635 Camino de los Mares 205
San Clemente, CA 92673
USA
Email Address
Overview
AtaCor Medical, Inc. is a developing the world's first implantable cardiac pacing system that doesn't require any wires (leads) or hardware to be placed inside or onto the heart. AtaCor's delivery tool can safely insert the custom lead, without any need for fluoroscopy or other medical imaging and can be used to delivery temporary and/or permanent pacing.
Profile
AtaCor Medical LinkedIn Company Profile
Social Media
AtaCor Medical Company Twitter Account
Company News
AtaCor Medical News
Facebook
AtaCor Medical on Facebook
YouTube
AtaCor Medical on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Richard Sanghera
  Richard Sanghera LinkedIn Profile  Richard Sanghera Twitter Account  Richard Sanghera News  Richard Sanghera on Facebook
Chief Medical Officer
Marty Burke
  Marty Burke LinkedIn Profile  Marty Burke Twitter Account  Marty Burke News  Marty Burke on Facebook
VP - General Counsel
Sean McGeehan
  Sean McGeehan LinkedIn Profile  Sean McGeehan Twitter Account  Sean McGeehan News  Sean McGeehan on Facebook
VP - Regulatory Affairs
Alan Marcovecchio
  Alan Marcovecchio LinkedIn Profile  Alan Marcovecchio Twitter Account  Alan Marcovecchio News  Alan Marcovecchio on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/25/2024: Diddo venture capital transaction
Next: 4/25/2024: Cerevance venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC transactions reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary